SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-202123"
 

Search: onr:"swepub:oai:DiVA.org:umu-202123" > Thromboembolic even...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer : a study of renal impairment in relation to potential thromboprophylaxis

Rydell, Harriet (author)
Umeå universitet,Urologi och andrologi
Ericson, Anna (author)
Umeå universitet,Urologi och andrologi
Eriksson, Victoria (author)
Umeå universitet,Urologi och andrologi
show more...
Johansson, Markus (author)
Umeå universitet,Urologi och andrologi,Department of Surgery, Urology Section, Sundsvall-Härnösand Hospital, Sundsvall, Sweden
Svensson, Johan, 1978- (author)
Umeå universitet,Statistik
Banday, Viqar Showkat (author)
Umeå universitet,Urologi och andrologi
Sherif, Amir (author)
Umeå universitet,Urologi och andrologi
show less...
 (creator_code:org_t)
2022-11-27
2022
English.
In: Journal of Personalized Medicine. - : MDPI. - 2075-4426. ; 12:12
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Recent studies on patients with muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC) have shown an association between NAC and thromboembolic events (TEE) prior to radical cystectomy (RC). Recent studies suggest that central venous access catheters (CVAs) may induce TEEs, and low-molecular-weight heparin (LMWH) has been mentioned as possible prophylaxis. However, other studies have shown a high incidence of decreased renal function in these patients. The purpose of this study was to determine the portion of MIBC patients with NAC-induced TEEs who had decreased preoperative renal function for whom LMWH potentially would not be beneficial as prophylaxis. We identified 459 cystectomized MIBC patients from two Swedish medical centers from 2009 to 2021. The inclusion criterion of cT2-T4aN0M0 resulted in 220 eligible patients, who were further divided into NAC-administered (n = 187) and NAC-eligible (n = 33), the tentative control group. Values of renal function before, during, and after each NAC cycle were retrospectively collected from individual medical records. Amongst the NAC-administered patients with TEE (n = 29), 41% (95% CI 23.5-61.1%) of patients had decreased renal function. Thus, a substantial portion of NAC-administered patients who developed TEEs had reduced renal function and would have been less likely to have benefited from renal clearance-dependent LMWH prophylaxis.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

Keyword

complications
cystectomy
low-molecular-weight heparin
neoadjuvant therapy
thromboembolism
urinary bladder neoplasms

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view